skip to main content
DOE PAGES title logo U.S. Department of Energy
Office of Scientific and Technical Information

This content will become publicly available on August 27, 2020

Title: Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae

Authors:
 [1];  [1];  [1]
  1. Division of Food Microbiology Defence Food Research Laboratory Mysore India
Publication Date:
Sponsoring Org.:
USDOE Office of Electricity Delivery and Energy Reliability (OE), Power Systems Engineering Research and Development (R&D) (OE-10)
OSTI Identifier:
1559100
Resource Type:
Publisher's Accepted Manuscript
Journal Name:
APMIS
Additional Journal Information:
Journal Name: APMIS Journal Volume: 127 Journal Issue: 10; Journal ID: ISSN 0903-4641
Publisher:
Wiley-Blackwell
Country of Publication:
Country unknown/Code not available
Language:
English

Citation Formats

Sreerohini, Sagi, Balakrishna, Konduru, and Parida, Manmohan. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae. Country unknown/Code not available: N. p., 2019. Web. doi:10.1111/apm.12983.
Sreerohini, Sagi, Balakrishna, Konduru, & Parida, Manmohan. Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae. Country unknown/Code not available. doi:10.1111/apm.12983.
Sreerohini, Sagi, Balakrishna, Konduru, and Parida, Manmohan. Wed . "Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae". Country unknown/Code not available. doi:10.1111/apm.12983.
@article{osti_1559100,
title = {Oral immunization of mice with Lactococcus lactis expressing Shiga toxin truncate confers enhanced protection against Shiga toxins of Escherichia coli O157:H7 and Shigella dysenteriae},
author = {Sreerohini, Sagi and Balakrishna, Konduru and Parida, Manmohan},
abstractNote = {},
doi = {10.1111/apm.12983},
journal = {APMIS},
number = 10,
volume = 127,
place = {Country unknown/Code not available},
year = {2019},
month = {8}
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on August 27, 2020
Publisher's Version of Record

Save / Share:

Works referenced in this record:

Protection against human papillomavirus type 16-induced tumors in C57BL/6 mice by mucosal vaccination with Lactococcus lactis NZ9000 expressing E6 oncoprotein
journal, January 2019


Lactococcus lactis as a live vector for mucosal delivery of therapeutic proteins
journal, April 2009


Evaluation of recombinant SEA-TSST fusion toxoid for protection against superantigen induced toxicity in mouse model
journal, September 2015


Treatment options for HUS secondary to Escherichia coli O157:H7
journal, February 2009


Verotoxins induce apoptosis in human renal tubular epithelium derived cells
journal, June 1998


Shiga Toxin (Stx) Classification, Structure, and Function
journal, August 2014


Oral immunization with recombinant Lactococcus lactis confers protection against respiratory pneumococcal infection
journal, October 2008

  • Villena, Julio; Medina, Marcela; Raya, Raúl
  • Canadian Journal of Microbiology, Vol. 54, Issue 10
  • DOI: 10.1139/W08-077

A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, inEscherichia coli
journal, December 2004

  • Kuczius, Thorsten; Bielaszewska, Martina; Friedrich, Alexander W.
  • Molecular Nutrition & Food Research, Vol. 48, Issue 7
  • DOI: 10.1002/mnfr.200400038

Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit
journal, September 2016


Pathogenesis and Diagnosis of Shiga Toxin-Producing Escherichia coli Infections
journal, July 1998

  • Paton, James C.; Paton, Adrienne W.
  • Clinical Microbiology Reviews, Vol. 11, Issue 3
  • DOI: 10.1128/CMR.11.3.450

Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome
journal, September 1997

  • Inward, Carol D.; Howie, Alec J.; Fitzpatrick, Margaret M.
  • Pediatric Nephrology, Vol. 11, Issue 5
  • DOI: 10.1007/s004670050337

Identification, Characterization, and Distribution of a Shiga Toxin 1 Gene Variant (stx1c) in Escherichia coli Strains Isolated from Humans
journal, April 2002


Haemolytic uraemic syndrome during shigellosis
journal, July 2012


Recent Progress of Shiga Toxin Neutralizer for Treatment of Infections by Shiga Toxin-Producing Escherichia coli
journal, June 2011


Mucosal Immunity and Protection Against HIV/SIV Infection: Strategies and Challenges for Vaccine Design
journal, January 2009

  • Demberg, Thorsten; Robert-Guroff, Marjorie
  • International Reviews of Immunology, Vol. 28, Issue 1-2
  • DOI: 10.1080/08830180802684331

Shiga Toxin Associated Hemolytic Uremic Syndrome
journal, June 2015


Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype
journal, March 2015

  • Rahal, Elias A.; Fadlallah, Sukayna M.; Nassar, Farah J.
  • Frontiers in Cellular and Infection Microbiology, Vol. 5
  • DOI: 10.3389/fcimb.2015.00024

The Hemolytic Uremic Syndrome
journal, December 1995


Antibody Therapy in the Management of Shiga Toxin-Induced Hemolytic Uremic Syndrome
journal, October 2004


Globotriaosyl ceramide receptor function - Where membrane structure and pathology intersect
journal, December 2009


New insights in mucosal vaccine development
journal, January 2012


Fusion expression and immunogenicity of EHEC EspA-Stx2Al protein: Implications for the vaccine development
journal, August 2009


Purification and characterization of verocytotoxin 2
journal, June 1988


The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model
journal, March 2015


Childhood Hemolytic Uremic Syndrome, United Kingdom and Ireland
journal, April 2005

  • Lynn, Richard M.; O'Brien, Sarah J.; Taylor, C. Mark
  • Emerging Infectious Diseases, Vol. 11, Issue 4
  • DOI: 10.3201/eid1104.040833

Modulation of Gut-Associated Lymphoid Tissue Functions with Genetically Modified Lactococcus lactis
journal, November 2009

  • Rottiers, Pieter; De Smedt, Tim; Steidler, Lothar
  • International Reviews of Immunology, Vol. 28, Issue 6
  • DOI: 10.3109/08830180903197498

Shigella sonnei and hemolytic uremic syndrome: A case report and literature review
journal, January 2017


10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis
journal, August 2005


Sex differences in vaccine-induced humoral immunity
journal, December 2018

  • Fischinger, Stephanie; Boudreau, Carolyn M.; Butler, Audrey L.
  • Seminars in Immunopathology, Vol. 41, Issue 2
  • DOI: 10.1007/s00281-018-0726-5

Effects of Antibiotics on Shiga Toxin 2 Production and Bacteriophage Induction by Epidemic Escherichia coli O104:H4 Strain
journal, March 2012

  • Bielaszewska, Martina; Idelevich, Evgeny A.; Zhang, Wenlan
  • Antimicrobial Agents and Chemotherapy, Vol. 56, Issue 6
  • DOI: 10.1128/AAC.06315-11

Oral immunization with Lactococcus lactis secreting attenuated recombinant staphylococcal enterotoxin B induces a protective immune response in a murine model
journal, January 2013

  • Asensi, Giselli Fernandes; de Sales, Nathalia Ferrari Fonseca; Dutra, Fabiano Ferreira
  • Microbial Cell Factories, Vol. 12, Issue 1
  • DOI: 10.1186/1475-2859-12-32